Lauren Mcdaniel resumes & CV records
Resumes
Lauren Mcdaniel
Lauren Mcdaniel
Lauren Mcdaniel
Lauren Mcdaniel
Lauren Mcdaniel
Lauren Mcdaniel
Lauren A Mcdaniel, 367911 111Th Ter E, Parrish, FL 34219
Lauren Mcdaniel Phones & Addresses
Parrish, FL
Overland Park, KS
Bradenton, FL
Mentions for Lauren A Mcdaniel
Publications & IP owners
Us Patents
Method Of Identifying Severe Acute Respiratory Syndrome Corona Virus 2 (Sars-Cov-2) Ribonucleic Acid (Rna)
US Patent:
2021013, May 6, 2021
Filed:
Dec 30, 2020
Appl. No.:
17/137972
Inventors:
- Morrisville NC, US
Steven BRUZEK - St. Petersburg FL, US
Chelsea KNAPP - Clearwater FL, US
Lauren McDANIEL - St. Petersburg FL, US
Jessica SMALL - Oldsmar FL, US
Robert ULRICH - Oldsmar FL, US
Victoria WAGNER - Rochester Hills MI, US
Steven BRUZEK - St. Petersburg FL, US
Chelsea KNAPP - Clearwater FL, US
Lauren McDANIEL - St. Petersburg FL, US
Jessica SMALL - Oldsmar FL, US
Robert ULRICH - Oldsmar FL, US
Victoria WAGNER - Rochester Hills MI, US
International Classification:
C12Q 1/6865
C12Q 1/6853
C12Q 1/6853
Abstract:
A method for detecting the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a biological sample includes the steps of lysing the biological sample to form a lysate and generating an amplified lysate by performing a nucleic acid sequence-based (NASBA) amplification for a target nucleic acid sequence in the lysate in the presence of: a forward primer having the oligonucleotide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 13, and SEQ ID NO: 17; a reverse primer having the oligonucleotide sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 14, and SEQ ID NO: 18; and a molecular beacon having the oligonucleotide sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 15, and SEQ ID NO: 19 and a fluorophore. The amplified lysate is exposed to an excitation source. A fluorescence of the fluorophore is detected in the amplified lysate exposed to the excitation source The SARS-CoV-2 is determined to be present in the biological sample in response to detecting the fluorescence of the fluorophore.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.